This inventor holds 1 USPTO granted patent. Top assignee: Aberdeen University. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Innovations in Ultrasound Technology by Kwok K Chan
Introduction
Kwok K Chan is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of ultrasound technology, particularly in the area of hyperthermia treatment for target tissues. His innovative approach has the potential to enhance therapeutic outcomes while minimizing collateral damage.
Latest Patents
Kwok K Chan holds a patent for a groundbreaking invention titled "Divergent ultrasound arrays." This ultrasound hyperthermia unit is designed for the treatment of target tissues. It features an ultrasound transducer array that is angled to direct sonic energy toward a target. The array comprises a plurality of divergent transducers arranged radially around a central axis, providing a coherent treatment field. Additionally, the invention includes temperature sensing means that can provide output signals indicative of temperature values adjacent to a target tumor. This information is utilized to control the output of the transducers. A liquid bath may also be incorporated to warm or induce local hyperthermia in the skin surface, allowing for effective treatment of physiotherapeutic conditions or neoplastic tissues.
Career Highlights
Kwok K Chan is affiliated with Aberdeen University, where he continues to advance his research and innovations in ultrasound technology. His work has garnered attention for its potential applications in medical treatments.
Collaborations
Kwok K Chan collaborates with David J Watmough, contributing to the development and refinement of ultrasound technologies.
Conclusion
Kwok K Chan's innovative work in ultrasound technology exemplifies the potential for advancements in medical treatments. His contributions are paving the way for more effective therapies with reduced risks.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile